GeneDx Q1 revenue $87.1M, exome/genome revenue up 62% YoY; raises FY 2025 guidance

GeneDx Holdings Corp.

2025-Q1 EPS reported -$0.23 revenue$87,115,000

Q1 exome/genome revenue $71.4M (+62% YoY); total revenue $87.1M (+42% YoY).
Adjusted net income $7.7M vs loss of $8.0M a year ago; GAAP net loss $6.5M.
Announced plans to acquire Fabric Genomics; no deal value disclosed.
Raised FY 2025 revenue guidance to $360-375M; reaffirms exome/genome growth of at least 30%.
Adjusted gross margin improved to 69% from 61% YoY; cash $160.2M at quarter-end.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.